The Aid Genomics Cancer Risk Profile panel is a comprehensive next generation sequencing (NGS) genomic test that simultaneously analyzes 76 genes for high risk, high/moderate risk, and multi-cancer risk assessments.
Genetic alterations in these genes have been associated with increased risk for multiple cancers including breast, ovarian, pancreas, colorectal, prostate, bladder, urinary, endocrine.
This test is designed for heritable germline mutations and the identification of a cancer-causing variant might also be beneficial for relatives that may be at-risk.
Aid Genomics can provide Mutation-Specific testing for known familial mutations, for families that were previously tested at GeneSort or elsewhere. Mutation-Specific Testing is offered for both symptomatic and asymptomatic individuals.
Saliva - Oral rinse for saliva is collected in 2 mL of mouthwash.
Blood – One EDTA tube with 3-5 mL blood.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. quis nostrud exercitation ullamco laboris nisi ut aliquip.
Donec id elit non mi porta gravida at eget metus. Sed posuere consectetur est at lobortis. Praesent commodo cursus magna, vel scelerisque nisl consectetur et.Maecenas sed diam eget risus varius blandit sit amet non magna. Vestibulum id ligula porta felis euismod semper. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cras mattis consectetur purus sit amet fermentum. Nullam id dolor id nibh ultricies vehicula ut id elit.